CXBS (Corix Bioscience) Other Current Liabilities: $0.70 Mil (As of Sep. 2017)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Corix Bioscience Other Current Liabilities?

Corix Bioscience CXBS -99.00% Other Current Liabilities is $0.70 Mil as of Sep. 2017.

Corix Bioscience's other current liabilities for the quarter that ended in Sep. 2017 was $0.70 Mil.

Corix Bioscience's quarterly other current liabilities increased from Mar. 2017 ($0.00 Mil) to Jun. 2017 ($0.36 Mil) and increased from Jun. 2017 ($0.36 Mil) to Sep. 2017 ($0.70 Mil).

Corix Bioscience's annual other current liabilities declined from Jan. 2014 ($0.00 Mil) to Jan. 2015 ($0.00 Mil) but then increased from Jan. 2015 ($0.00 Mil) to Dec. 2016 ($0.00 Mil).

Corix Bioscience Other Current Liabilities Related Terms

Corix Bioscience Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Corix Bioscience's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Corix Bioscience Other Current Liabilities Chart

Corix Bioscience Annual Data
Trend Jan09 Jan10 Jan11 Jan12 Jan13 Jan14 Jan15 Dec16
Other Current Liabilities
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Corix Bioscience Quarterly Data
Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.36 0.70

Corix Bioscience Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $0.70 Mil mean?
Corix Bioscience (CXBS) has a Other Current Liabilities of $0.70 Mil as of Sep. 2017. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Corix Bioscience.
Is Corix Bioscience's Other Current Liabilities too high?
Corix Bioscience's current Other Current Liabilities is $0.70 Mil.
How does Corix Bioscience's Other Current Liabilities compare to BKIT and YBAO?
Corix Bioscience's Other Current Liabilities of $0.70 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Corix Bioscience. Corix Bioscience's current Other Current Liabilities is $0.70 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corix Bioscience stock overvalued right now?
Corix Bioscience (CXBS) has a current Other Current Liabilities of $0.70 Mil. The current Other Current Liabilities is $0.70 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Corix Bioscience (CXBS), the current Other Current Liabilities is $0.70 Mil as of Sep. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Corix Bioscience Business Description

Address 18662 MaCaurther Boulevard, Suite 200, Irvine, CA, USA, 85085
Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.